Print page Close print preview
Logo Going International

TCR-based Therapies for Solid Tumors Summit

Evvnt Promotion / evvnt
03.04.2023 - 05.04.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 09:00 to 16:30
Temas de la conferencia
The first TCR-based therapy approval in the US and Europe at the start of this year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it's time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to guarantee smooth sailing through the clinic.
La Sociedad Científica
Hanson Wade

Speakers: Birgit Schultes, Senior Vice President, Cell Therapy, Intellia Therapeutics, Claudia Wagner, Senior Director, Immunology, Head of TCR Discovery and Validation, Immatics, and more

Información e inscripción:
Ms. Ellie Saunders
Medicina General
Cuota del Congreso
USD 2599.00 - USD 5997.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom